Wellcome Leap Psilocybin for OUD

Clinical trial NCT06786325 · RECRUITING

Trial details

NCT number: NCT06786325
Sponsor: Anna Rose Childress, Ph.D.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid Use Disorder

Start date: 2025-10-07
Primary completion: 2027-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.